icon-folder.gif   Conference Reports for NATAP  
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
The Impact of Fibrosis on the Risk of Long-Term Morbidity & Mortality in Chronic Hepatitis C Patients Treated in the US Veterans Health Administration Health Care System - advanced HCV disease correlated with risk for hospitalization/events/death
  This study illustrates the impact of fibrosis level & treatment on the risk for hospitalization, events & death in HCV patients....from Jules: it is well known & accepted that waiting to treat a person with HCV until after they have advanced disease (F3/F4) increases the risk for liver cancer.
Reported by Jules Levin
EASL 2014 London, UK